Name: Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells (Video) | JoVE Journal
Uploaded: 2022-09-23T13:00:00.000+00:00
Duration: 7 min 3 s
Description: Learn differential centrifugation for isolating extracellular vesicles from human mesenchymal stem cells. This reproducible method enables scalable collection of exosomes and microvesicles for therapeutic research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by grants from the National Natural Science Foundation of China (32000974, 81930025, and 82170988) and the China Postdoctoral Science Foundation (2019M663986 and BX20190380). We are grateful for the assistance of the National Experimental Teaching Demonstration Center for Basic Medicine (AMFU) and the Analytical and Testing Central Laboratory of Military Medical Innovation Center of Air Force Medical University.

All animal procedures were approved by the Animal Care and Use Committee of the Fourth Military Medical University and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Eight-week-old C57Bl/6 mice (no preference for either females or males) were used. Cryopreserved human umbilical cord-derived MSCs (UCMSCs), used for the present study, were obtained from a commercial source (see Table of Materials). The use of human cells was approved by the Ethics Committee of Fourth Military Medical University.
1. Culture of human mesenchymal stem cells (hMSCs)
<ol>
	<li>Prepare the accessories and solutions required for the experimental work, including pipettes, pipette tips, 10 cm Petri dish, thermostatic equipment (water bath), rubber gloves, 75% alcohol, culture medium (incubated at 37 &#176;C), fatal bovine serum (FBS), and 100x penicillin-streptomycin (P/S) solution (see Table of Materials).</li>
	<li>Prepare commercially available alpha-Minimum Essential Medium (&#945;-MEM) by supplementing with 20% FBS and 1% P/S. 
	NOTE: Dilute all the solutions used for isolation and analysis of EVs in ultrapure filtered water made by the ultrapure filtered water purification system (see Table of Materials).</li>
	<li>Recover the cryopreserved human umbilical cord-derived MSCs (UCMSCs) from the liquid nitrogen by melting them in a 37 &#176;C water bath.</li>
	<li>Quickly and gently transfer the melted cell suspension into a 15 mL tube with 5 mL of culture medium (step 1.2). Centrifuge at 4 &#176;C, 500 x g for 5 min.</li>
	<li>Remove the supernatant with a sterile pipette and retain the cell precipitate. Add 2 mL of culture medium into the centrifuge tube and gently resuspend the cells.</li>
	<li>Seed the cells in a 10 cm Petri dish, and add 8 mL of culture medium to a total of 10 mL.</li>
	<li>Culture MSCs at 37 &#176;C in 5% CO2 in the cell incubator.</li>
</ol>
2. Differential centrifugation for isolation of Exos and MVs
<ol>
	<li>When MSCs grow to &#62;90% confluence, replace the culture medium with &#945;-MEM supplemented with 20% EV-depleted FBS and 1% P/S for 8 mL of each dish. 
	NOTE: Centrifuge FBS at 4 &#176;C, 1,50,000 x g overnight to remove EVs and other impurities.</li>
	<li>After 48 h of culture, collect the culture medium (step 2.1) into 50 mL centrifuge tubes.</li>
	<li>Centrifuge the MSC culture medium at 4 &#176;C, 800 x g for 10 min.</li>
	<li>Remove the cell fragments and cellular debris by transferring the supernatant to clean 1.5 mL conical tubes. 
	NOTE: Using 1.5 mL conical tubes is necessary to increase EV yield.</li>
	<li>Centrifuge the supernatant at 4 &#176;C, 16,000 x g for 30 min. The pellet is MVs. MVs from each dish of cells were resuspended with 50 &#181;L of PBS.</li>
	<li>Transfer the supernatant obtained by centrifugation in step 2.5 by pipette to clean ultracentrifuge tubes. Centrifuge at 1,50,000 x g for 2 h at 4 &#176;C.</li>
	<li>Discard the supernatant and collect the residue, which is Exos. Resuspend Exos from seven dishes of cells in 50 &#181;L of PBS. 
	NOTE: The sixth-passaged UCMSCs are used for EV isolation. To get enough MVs and Exos for experimental use, 7-8 dishes of cultured cells are usually needed. The EV samples are used immediately for the following characterization steps or for therapeutic application, which is better not stored. 
	CAUTION: Avoid repeated freezing and thawing of EVs, and it is best to store EVs at 4 &#176;C in the short term and not at -80 &#176;C.</li>
</ol>
3. Detection of particle numbers and size distribution of EVs from MSCs
NOTE: For size distribution evaluation, nanoparticle tracking analysis (NTA) is performed by a commercially available nanoparticle tracking analyzer (see Table of Materials).
<ol>
	<li>Dilute 1 &#181;L of EVs (from step 2.5 and step 2.7) in 1,499 &#181;L of PBS and mix enough in a 15 mL tube.</li>
	<li>Operate the tracking analyzer following the manufacturer&#39;s instructions. Firstly, start the compatible software (see Table of Materials).</li>
	<li>Fill the sample cell with distilled water, and then allow the instrument to start the cell check.</li>
	<li>Calibrate the instrument with a prepared standard solution. Ensure that the particle number displayed on the software detection interface is between 50-400 (preferably around 200). Click OK. 
	NOTE: Prepare the standard solution by reconstituting 1 &#181;L of calibration solution (see Table of Materials) in 1 mL of distilled water to generate a primary solution, and then take 100 &#181;L of the primary solution and add 25 mL of distilled water to prepare a standard solution (1:250,000). Store this working reagent at 4 &#176;C for a week.</li>
	<li>Rinse the sample cell with 5 mL of distilled water.</li>
	<li>Before sample analysis, flush the channel with 1 mL of distilled water. Ensure that the particle number displayed on the software detection interface is less than 10.</li>
	<li>Inject 1 mL of the EV sample prepared in step 3.1. Perform vesicle test according to the operating instructions of the instrument. 
	CAUTION: The sample and distilled water are injected with a 1 mL syringe at a constant speed of 0.5 mL/s under careful manual control.</li>
</ol>
4. Characterization of EV morphology by transmission electron microscope (TEM)
<ol>
	<li>Dilute 1 &#181;L of EVs from step 2.7 in 199 &#181;L of PBS and mix enough. Add 20 &#181;L of EV suspension drops to the formvar/carbon-coated square mesh (see Table of Materials), and let it stay for 3 min.</li>
	<li>Remove excess liquid by a small filter paper, and let it stay for 15 s to slightly dry the surface.</li>
	<li>Negatively stain EV samples with 1.5% phosphotungstic acid droplets for 40 s.</li>
	<li>Remove the excess phosphotungstic acid and allow it to stand for 15 s to slightly dry the surface.</li>
	<li>Put the sample containing formvar/carbon-coated square mesh into a clean dish covered with filter papers. Observe and capture images with a transmission electron microscope. 
	NOTE: In this process, Exos are taken as an example.</li>
</ol>
5. Labeling of MSCs-derived EVs
<ol>
	<li>After EVs extraction (step 2.5), resuspend with 250 &#181;L of PBS in a 1.5 mL conical tube.</li>
	<li>Use another 1.5 mL conical tube for preparing the working solution of the PKH26 dye; use 1 &#181;L of PKH26 labeling reagent diluted with 250 &#181;L of Diluent C (a component of the commercially available EV labeling kit used for the present study, see Table of Materials). 
	NOTE: Prepare the working solution immediately before use. 
	CAUTION: Excessive PKH26 dye or labeling without pre-dilution is at risk of damaging the EVs.</li>
	<li>Mix the resuspended EVs with the working solution. Allow it to stand at room temperature for 5 min, and then add 500 &#181;L of EV-depleted FBS to stop the reaction.</li>
	<li>For MVs, centrifuge at 4 &#176;C, 16,000 x g for 30 min, and discard the supernatant by a pipette. Add 1 mL of PBS to rinse the residue.</li>
	<li>Centrifuge at 4 &#176;C, 16,000 x g for 30 min, and discard the supernatant to remove the unbound dye.</li>
	<li>Resuspend the residue with 200 &#181;L of PBS. Drop 20 &#181;L of suspension on the slide and observe it under a fluorescence microscope. 
	NOTE: In this process, MVs are taken as an example.</li>
</ol>
6. Local transplantation and systemic injection of MSC-EVs
NOTE: For the following procedures, place the EVs on ice before injection.
<ol>
	<li>Perform local transplantation following the steps below.
	<ol>
		<li>Anesthetize the mice with 4% (vol/vol) isoflurane.&#160;Maintain anesthesia at 1%-3% isoflurane during the procedure.</li>
		<li>Before the surgery, administer 5 mg/kg carprofen (IP) for analgesia to minimize postprocedural pain.</li>
		<li>Before wound excision, shave the dorsal hair and sterilize the dorsal surface by applying 3 alternating rounds of 10% povidone-iodine and 75% ethanol.&#160;</li>
		<li>Using a biopsy punch (see Table of Materials), create a full-thickness wound of 1 cm in diameter on the dorsal skin.</li>
		<li>Resuspend the MSC-derived EVs from two dishes in 100 &#181;L of PBS and administer the injection in the subcutaneous layer of the wound bed, around each wound with four sites. 
		NOTE: An average of 100 &#181;g of EVs per mouse (EVs from two 10 cm dishes of cells) is injected. Ten 10 cm dishes of MSCs are needed to yield enough EVs to set up an experiment of n = 5 in a murine model.</li>
		<li>After treatment, wrap the mice with sterile gauze and place them on heat insulation pads (see Table of Materials) until they wake up.</li>
		<li>Ensure that the mice are not left unattended until they have regained sufficient consciousness. Do not return the mice to the company of other animals until they have fully recovered.</li>
		<li>Administer additional doses of analgesia on day 2 and day 3 post-surgery as required.&#160;</li>
	</ol>
	</li>
	<li>Perform systemic injection.
	<ol>
		<li>Resuspend MSC-derived EVs in 200 &#181;L of PBS, and then mix with heparin solution at a 10:1 volume ratio.</li>
		<li>Place the mice into the caudal vein imaging system (see Table of Materials). Press the switch to lift the lever.</li>
		<li>Disinfect the tail vein using an alcohol pad before the IV injection. Then, inject the mice systematically with suspension prepared in step 6.2.1 through the tail vein. The procedure is helped by a tail vein illustrator. 
		NOTE: Inject EV suspension immediately after mixing with heparin. An average of 100 &#181;g EVs per mouse (EVs from two 10 cm dishes of cells) is injected. Ten 10 cm dishes of MSCs are needed to yield enough EVs to set up an experiment of n = 5 in a murine model. 
		CAUTION: Mouse tail vein injection is usually limited to 200 &#181;l of volume. The injection should go slowly and stop if you see a bump or resistance, which suggests the needle is out of the vein. If the mice show&#160;adverse clinical signs like curling and trembling, this could be a shock response to high-volume injection, fast injection, or toxicity/anaphylaxis.</li>
	</ol>
	</li>
</ol>

<ol><li>Liu, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+application+of+MSCs-derived+extracellular+vesicles+in+bone+disorders%3A+Novel+cell-free+therapeutic+strategy%5BTitle%5D)+AND+%22Frontiers+in+Cell+and+Developmental+Biology%22%5BJournal%5D)">The application of MSCs-derived extracellular vesicles in bone disorders: Novel cell-free therapeutic strategy.</a> Frontiers in Cell and Developmental Biology. 8, 619(2020).</li>
<li>Arthur, A., Zannettino, A., Gronthos, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+therapeutic+applications+of+multipotential+mesenchymal%2Fstromal+stem+cells+in+skeletal+tissue+repair%5BTitle%5D)+AND+%22Journal+of+Cellular+Physiology%22%5BJournal%5D)">The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair.</a> Journal of Cellular Physiology. 218 (2), 237-245 (2009).</li>
<li>Zhou, Y., Yamamoto, Y., Xiao, Z., Ochiya, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+immunomodulatory+functions+of+mesenchymal+stromal%2Fstem+cells+mediated+via+paracrine+activity%5BTitle%5D)+AND+%22Journal+of+Clinical+Medicine%22%5BJournal%5D)">The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity.</a> Journal of Clinical Medicine. 8 (7), 1025(2019).</li>
<li>Mathieu, M., Martin-Jaular, L., Lavieu, G., Thery, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Specificities+of+secretion+and+uptake+of+exosomes+and+other+extracellular+vesicles+for+cell-to-cell+communication%5BTitle%5D)+AND+%22Nature+Cell+Biology%22%5BJournal%5D)">Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication.</a> Nature Cell Biology. 21 (1), 9-17 (2019).</li>
<li>Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandao, B. B., Kahn, C. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Extracellular+miRNAs%3A+From+Biomarkers+to+Mediators+of+Physiology+and+Disease%5BTitle%5D)+AND+%22Cell+Metabolism%22%5BJournal%5D)">Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease.</a> Cell Metabolism. 30 (4), 656-673 (2019).</li>
<li>Lei, L. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Exosomes+and+Obesity-Related+Insulin+Resistance%5BTitle%5D)+AND+%22Frontiers+in+Cell+and+Developmental+Biology%22%5BJournal%5D)">Exosomes and Obesity-Related Insulin Resistance.</a> Frontiers in Cell and Developmental Biology. 9, 651996(2021).</li>
<li>Isaac, R., Reis, F. C. G., Ying, W., Olefsky, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Exosomes+as+mediators+of+intercellular+crosstalk+in+metabolism%5BTitle%5D)+AND+%22Cell+Metabolism%22%5BJournal%5D)">Exosomes as mediators of intercellular crosstalk in metabolism.</a> Cell Metabolism. 33 (9), 1744-1762 (2021).</li>
<li>Gatti, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Microvesicles+derived+from+human+adult+mesenchymal+stem+cells+protect+against+ischaemia-reperfusion-induced+acute+and+chronic+kidney+injury%5BTitle%5D)+AND+%22Nephrology+Dialysis+Transplantation%22%5BJournal%5D)">Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.</a> Nephrology Dialysis Transplantation. 26 (5), 1474-1483 (2011).</li>
<li>Thery, C., Amigorena, S., Raposo, G., Clayton, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isolation+and+characterization+of+exosomes+from+cell+culture+supernatants+and+biological+fluids%5BTitle%5D)+AND+%22Current+Protocols+In+Cell+Biology%22%5BJournal%5D)">Isolation and characterization of exosomes from cell culture supernatants and biological fluids.</a> Current Protocols In Cell Biology. , Chapter 3, Unit 3 22(2006).</li>
<li>Cheruvanky, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rapid+isolation+of+urinary+exosomal+biomarkers+using+a+nanomembrane+ultrafiltration+concentrator%5BTitle%5D)+AND+%22American+Journal+of+Physiology-Renal+Physiology%22%5BJournal%5D)">Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.</a> American Journal of Physiology-Renal Physiology. 292 (5), 1657-1661 (2007).</li>
<li>Zarovni, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Integrated+isolation+and+quantitative+analysis+of+exosome+shuttled+proteins+and+nucleic+acids+using+immunocapture+approaches%5BTitle%5D)+AND+%22Methods%22%5BJournal%5D)">Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.</a> Methods. 87, 46-58 (2015).</li>
<li>Boing, A. N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Single-step+isolation+of+extracellular+vesicles+by+size-exclusion+chromatography%5BTitle%5D)+AND+%22Journal+of+Extracellular+Vesicles%22%5BJournal%5D)">Single-step isolation of extracellular vesicles by size-exclusion chromatography.</a> Journal of Extracellular Vesicles. 3, (2014).</li>
<li>Chen, I. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Phosphoproteins+in+extracellular+vesicles+as+candidate+markers+for+breast+cancer%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.</a> Proceedings of the National Academy of Sciences of the United States of America. 114 (12), 3175-3180 (2017).</li>
<li>Li, P., Kaslan, M., Lee, S. H., Yao, J., Gao, Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Progress+in+exosome+isolation+techniques%5BTitle%5D)+AND+%22Theranostics%22%5BJournal%5D)">Progress in exosome isolation techniques.</a> Theranostics. 7 (3), 789-804 (2017).</li>
<li>Lobb, R. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Optimized+exosome+isolation+protocol+for+cell+culture+supernatant+and+human+plasma%5BTitle%5D)+AND+%22Journal+of+Extracellular+Vesicles%22%5BJournal%5D)">Optimized exosome isolation protocol for cell culture supernatant and human plasma.</a> Journal of Extracellular Vesicles. 4, 27031(2015).</li>
<li>Liu, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((MSC+Transplantation+Improves+Osteopenia+via+Epigenetic+Regulation+of+Notch+Signaling+in+Lupus%5BTitle%5D)+AND+%22Cell+Metabolism%22%5BJournal%5D)">MSC Transplantation Improves Osteopenia via Epigenetic Regulation of Notch Signaling in Lupus.</a> Cell Metabolism. 22 (4), 606-618 (2015).</li>
<li>Deng, C. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Photoreceptor+protection+by+mesenchymal+stem+cell+transplantation+identifies+exosomal+MiR-21+as+a+therapeutic+for+retinal+degeneration%5BTitle%5D)+AND+%22Cell+Death+and+Differentiation%22%5BJournal%5D)">Photoreceptor protection by mesenchymal stem cell transplantation identifies exosomal MiR-21 as a therapeutic for retinal degeneration.</a> Cell Death and Differentiation. 28 (3), 1041-1061 (2021).</li>
<li>Wu, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((SHED+aggregate+exosomes+shuttled+miR-26a+promote+angiogenesis+in+pulp+regeneration+via+TGF-beta%2FSMAD2%2F3+signalling%5BTitle%5D)+AND+%22Cell+Proliferation%22%5BJournal%5D)">SHED aggregate exosomes shuttled miR-26a promote angiogenesis in pulp regeneration via TGF-beta/SMAD2/3 signalling.</a> Cell Proliferation. 54 (7), 13074(2021).</li>
<li>Qiu, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Exosomes+released+from+educated+mesenchymal+stem+cells+accelerate+cutaneous+wound+healing+via+promoting+angiogenesis%5BTitle%5D)+AND+%22Cell+Proliferation%22%5BJournal%5D)">Exosomes released from educated mesenchymal stem cells accelerate cutaneous wound healing via promoting angiogenesis.</a> Cell Proliferation. 53 (8), 12830(2020).</li>
<li>He, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((MSC-derived+exosome+promotes+M2+polarization+and+enhances+cutaneous+wound+healing%5BTitle%5D)+AND+%22Stem+Cells+International%22%5BJournal%5D)">MSC-derived exosome promotes M2 polarization and enhances cutaneous wound healing.</a> Stem Cells International. 2019, 7132708(2019).</li>
<li>Cheng, L., Hill, A. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Therapeutically+harnessing+extracellular+vesicles%5BTitle%5D)+AND+%22Nature+Reviews+Drug+Discovery%22%5BJournal%5D)">Therapeutically harnessing extracellular vesicles.</a> Nature Reviews Drug Discovery. 21 (5), 379-399 (2022).</li>
<li>Théry, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Minimal+information+for+studies+of+extracellular+vesicles+2018+%28MISEV2018%29%3A+a+position+statement+of+the+International+Society+for+Extracellular+Vesicles+and+update+of+the+MISEV2014+guidelines%5BTitle%5D)+AND+%22Journal+of+Extracellular+Vesicles%22%5BJournal%5D)">Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.</a> Journal of Extracellular Vesicles. 7 (1), 1535750(2018).</li>
<li>Nielsen, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Extracellular+vesicle-associated+procoagulant+phospholipid+and+tissue+factor+activity+in+multiple+myeloma%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma.</a> PLoS One. 14 (1), 0210835(2019).</li>
<li>Zheng, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Apoptotic+vesicles+restore+liver+macrophage+homeostasis+to+counteract+type+2+diabetes%5BTitle%5D)+AND+%22Journal+of+Extracellular+Vesicles%22%5BJournal%5D)">Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes.</a> Journal of Extracellular Vesicles. 10 (7), 12109(2021).</li>
<li>Gelibter, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+impact+of+storage+on+extracellular+vesicles%3A+A+systematic+study%5BTitle%5D)+AND+%22Journal+of+Extracellular+Vesicles%22%5BJournal%5D)">The impact of storage on extracellular vesicles: A systematic study.</a> Journal of Extracellular Vesicles. 11 (2), 12162(2022).</li>
<li>Dehghani, M., Gulvin, S. M., Flax, J., Gaborski, T. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Systematic+evaluation+of+PKH+labelling+on+extracellular+vesicle+size+by+nanoparticle+tracking+analysis%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Systematic evaluation of PKH labelling on extracellular vesicle size by nanoparticle tracking analysis.</a> Scientific Reports. 10 (1), 9533(2020).</li>
<li>Zeringer, E., Barta, T., Li, M., Vlassov, A. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Strategies+for+isolation+of+exosomes%5BTitle%5D)+AND+%22Cold+Spring+Harbor+Protocols%22%5BJournal%5D)">Strategies for isolation of exosomes.</a> Cold Spring Harbor Protocols. 2015 (4), 319-323 (2015).</li>
<li>Bosch, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Trehalose+prevents+aggregation+of+exosomes+and+cryodamage%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Trehalose prevents aggregation of exosomes and cryodamage.</a> Scientific Reports. 6, 36162(2016).</li>
<li>Williams, A. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mesenchymal+stem+cell-derived+exosomes+provide+neuroprotection+and+improve+long-term+neurologic+outcomes+in+a+swine+model+of+traumatic+brain+injury+and+hemorrhagic+shock%5BTitle%5D)+AND+%22Journal+of+Neurotrauma%22%5BJournal%5D)">Mesenchymal stem cell-derived exosomes provide neuroprotection and improve long-term neurologic outcomes in a swine model of traumatic brain injury and hemorrhagic shock.</a> Journal of Neurotrauma. 36 (1), 54-60 (2019).</li>
<li>Li, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Apoptotic+vesicles+activate+autophagy+in+recipient+cells+to+induce+angiogenesis+and+dental+pulp+regeneration%5BTitle%5D)+AND+%22Molecular+Therapy%3A+The+Journal+of+the+American+Society+of+Gene+Therapy%22%5BJournal%5D)">Apoptotic vesicles activate autophagy in recipient cells to induce angiogenesis and dental pulp regeneration.</a> Molecular Therapy: The Journal of the American Society of Gene Therapy. 1525 (22), 00304-00305 (2022).</li>
<li>Nozaki, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Significance+of+a+multiple+biomarkers+strategy+including+endothelial+dysfunction+to+improve+risk+stratification+for+cardiovascular+events+in+patients+at+high+risk+for+coronary+heart+disease%5BTitle%5D)+AND+%22Journal+of+the+American+College+of+Cardiology%22%5BJournal%5D)">Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.</a> Journal of the American College of Cardiology. 54 (7), 601-608 (2009).</li>
<li>Qi, Y., Ma, J., Li, S., Liu, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Applicability+of+adipose-derived+mesenchymal+stem+cells+in+treatment+of+patients+with+type+2+diabetes%5BTitle%5D)+AND+%22Stem+Cell+Research+and+Therapy%22%5BJournal%5D)">Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes.</a> Stem Cell Research and Therapy. 10 (1), 274(2019).</li>
<li>Kumar, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((High-fat+diet-induced+upregulation+of+exosomal+phosphatidylcholine+contributes+to+insulin+resistance%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance.</a> Nature Communications. 12 (1), 213(2021).</li>
</ol>

The authors have no conflicts of interest to disclose.

EVs are emerging to play an important role in diverse biological activities, including antigen presentation, genetic material transport, cell microenvironment modification, and others. Furthermore, their wide application brings new approaches and opportunities for diagnosing and treating diseases21. Implementation of therapeutic applications of EVs is based on successful isolation and characterization. However, due to the lack of standardized isolation and purification methods and the low extracti...

Stem cells are undifferentiated pluripotent cells with self-renewal capability and translational potential1. Mesenchymal stem cells (MSCs) are easily isolated, cultured, expanded, and purified in the laboratory, which remains characteristic of stem cells after multiple passages. In recent years, increasing evidence has supported the view that MSCs act in a paracrine mode in therapeutic use2,3. Especially the secretion of extracellular vesicles (EVs) plays a crucial role in mediating the biological functions of MSCs. As heterogeneous membranous nanoparticles released from most cell types, EVs consist of subcategories termed exosomes (Exos), microvesicles (MVs), and even larger apoptotic bodies4,5. Among them, Exos is the most widely studied EV with a size of 40-150 nm, which is of an endosomal origin and actively secreted in physiological conditions. MVs are formed by shedding directly from the surface of the cell plasma membrane with a diameter of 100-1,000 nm, which are characterized by high expression of phosphatidylserine and expression of surface markers of donor cells6. EVs contain RNA, proteins, and other bioactive molecules, which have similar functions to the parent cells and play a significant role in cell communication, immune response, and tissue damage repair7. MSC-EVs have been widely investigated as a powerful cell-free therapeutic tool in regenerative medicine8.
Isolation and purification of MSC-derived EVs is a common issue in the field of research and application. At present, differential and density gradient ultracentrifugation9, ultrafiltration process10, immunomagnetic separation11, molecular exclusion chromatograph12, and microfluidic chip13 are widely employed methods in the isolation and purification of EVs. With the advantages and disadvantages of each approach, the quantity, purity, and activity of collected EVs cannot be satisfied at the same time14,15. In the present study, the differential centrifugation protocol of isolation and characterization of EVs from cultured MSCs is shown in detail, which has supported efficient therapeutic use16,17,18,19,20. The adaptability of this method for a series of downstream approaches, such as fluorescent labeling, local transplantation, and systemic injection, has further been exampled. Implementing this procedure will address the need for simple and reliable collection and application of MSC-EVs in translational research.

<table><tbody><tr><td>10% povidone-iodine (Betadine)</td><td>Weizhenyuan</td><td>10053956954292</td><td>Wound disinfection</td></tr><tr><td>Calibration solution</td><td>Particle Metrix</td><td>110-0020</td><td>Calibrate the NTA instrument</td></tr><tr><td>Carprofen</td><td>Sigma</td><td>53716-49-7</td><td>Analgesic medicine</td></tr><tr><td>Caudal vein imager&amp;nbsp;</td><td>KEW Life Science</td><td>KW-XXY</td><td>Caudal vein imager</td></tr><tr><td>Centrifuge</td><td>Eppendorf</td><td>5418R</td><td>Centrifugation</td></tr><tr><td>Fatal bovine serum</td><td>Corning</td><td>35-081-CV</td><td>Culture of UCMSCs</td></tr><tr><td>Formvar/carbon-coated square mesh</td><td>PBL Assay Science&amp;nbsp;</td><td>24916-25</td><td>Transmission electron microscope</td></tr><tr><td>Heating pad</td><td>Zhongke Life Science</td><td>Z8G5JBMz</td><td>Post-treatment care of animals</td></tr><tr><td>Heparin Solution</td><td>StemCell</td><td>7980</td><td>Systemic injection</td></tr><tr><td>Isoflurane</td><td>RWD Life Science</td><td>R510-22</td><td>Animal anesthesia</td></tr><tr><td>Minimum Essential Medium Alpha basic (1x)</td><td>Gibco</td><td>C12571500BT</td><td>Culture of UCMSCs</td></tr><tr><td>Nanoparticle tracking analyzer</td><td>Particle Metrix</td><td>ZetaView PMX120</td><td>Nanoparticle tracking analysis</td></tr><tr><td>PBS (1x)</td><td>Meilunbio</td><td>MA0015</td><td>Resuspend EVs</td></tr><tr><td>Penicillin/Streptomycin</td><td>Procell Life Science</td><td>PB180120</td><td>Culture of UCMSCs</td></tr><tr><td>Phosphotungstic acid</td><td>Solarbio</td><td>12501-23-4</td><td>Transmission electron microscope</td></tr><tr><td>Pipette</td><td>Eppendorf</td><td>3120000224</td><td></td></tr><tr><td>PKH26 Red Fluorescent Cell Linker Kit</td><td>Sigma-Aldrich</td><td>MINI26</td><td>Labeling EVs</td></tr><tr><td>Skin biopsy punch</td><td>Acuderm</td><td>69038-10-50</td><td>Skin defects</td></tr><tr><td>Software ZetaView</td><td>Particle Metrix</td><td>Version 8.05.14 SP7&amp;nbsp;</td><td></td></tr><tr><td>Thermostatic equipment</td><td>Grant</td><td>v-0001-0005</td><td>Water bath</td></tr><tr><td>Transmission electron microscope</td><td>HITACHI</td><td>HT7800</td><td>Transmission electron microscope</td></tr><tr><td>UCMSCs</td><td>Bai&#039;ao&amp;nbsp;</td><td>UKK220201</td><td>Commercially UCMSCs</td></tr><tr><td>Ultracentrifuge</td><td>Beckman</td><td>XPN-100</td><td>Centrifugation</td></tr><tr><td>Ultrapure filtered water purification system</td><td>Milli-Q</td><td>IQ 7000</td><td>Preparation of ultrapure water</td></tr></tbody></table>

isolation, characterization, and therapeutic application of extracellular vesicles from cultured human mesenchymal stem cells

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Extracellular vesicles (EVs) are heterogeneous membrane nanoparticles released by most cell types, and they are increasingly recognized as physiological regulators of organismal homeostasis and important indicators of pathologies; in the meantime, their immense potential to establish accessible and controllable disease therapeutics is emerging. Mesenchymal stem cells (MSCs) can release large amounts of EVs in culture, which have shown promise to jumpstart effective tissue regeneration and facilitate extensive therapeutic applications with good scalability and reproducibility. There is a growing demand for simple and effective protocols for collecting and applying MSC-EVs. Here, a detailed protocol is provided based on differential centrifugation to isolate and characterize representative EVs from cultured human MSCs, exosomes, and microvesicles for further applications. The adaptability of this method is shown for a series of downstream approaches, such as labeling, local transplantation, and systemic injection. The implementation of this procedure will address the need for simple and reliable MSC-EVs collection and application in translational research.

MVs and Exos from cultured human UCMSCs are isolated following the experimental workflow (Figure 1). The NTA results demonstrate that the size of Exos from human MSCs ranges from 40 nm to 335 nm with a peak size of about 100 nm, and the size of MVs ranges from 50 nm to 445 nm with a peak size of 150 nm (Figure 2). Morphological characterization of MSC-derived Exos exhibit a typical cup shape (Figure 3). EVs are efficiently labeled b...

The present protocol describes the differential centrifugation for isolating and characterizing representative EVs (exosomes and microvesicles) from cultured human MSCs. Further applications of these EVs are also explained in this article.

Extracellular vesicles (EVs) are heterogeneous membrane nanoparticles released by most cell types, and they are increasingly recognized as physiological ...

isolation-characterization-therapeutic-application-extracellular

Research

JoVE Journal

Biology

This protocol demonstrates how to purify extracellular microRNAs from cell culture media for small RNA library construction and next generation sequencing. Various quality control checkpoints are described to allow readers to understand what to expect when working with low input samples like exRNAs.

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells

Here, we present a protocol to produce a large number of GMP-grade exosomes from synovial fluid mesenchymal stem cells using a 3D bioreactor.

Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture

This protocol demonstrates how to isolate human umbilical cord-derived mesenchymal stem cells' small extracellular vesicles (hUC-MSC-sEVs) with a simple lab-scale benchtop setting. The size distribution, protein concentration, sEVs markers, and morphology of isolated hUC-MSC-sEVs are characterized by nanoparticle tracking analysis, BCA protein assay, western blot, and transmission electron microscope, respectively.

A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells

This protocol describes all procedures, from culturing human adipose-derived mesenchymal stem cells (ADSCs) and collecting supernatant to extracting extracellular vesicles (EVs) using ultracentrifugation.

Purification and Characterization of Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells

This protocol provides a detailed description of sorting extracellular vesicles (EVs) released by mesenchymal stromal cells. In particular, it focuses on the instrument setting and the optimization of the sorting conditions. The goal is to sort extracellular vesicles while preserving their characteristics.

Setting a Successful Sorting for Extracellular Vesicle Isolation

This protocol describes the isolation and subsequent expansion of mesenchymal stromal cells and endothelial colony forming cells without the use of animal serum to generate autologous pairs for experimental transplantation purposes.

Isolation and Animal Serum Free Expansion of Human Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) and Endothelial Colony Forming Progenitor Cells (ECFCs)

Cancer stem cells (CSCs) have been identified in a number of malignancies.  In this protocol we describe a flow cytometric method utilizing aldehyde dehydrogenase activity and CD44 and CD24 expression to isolate CSCs from human pancreatic adenocarcinoma xenografts.  These viable cells can then be used in functional and analytical studies.

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

A rapid, robust way of isolating viable adult epithelial stem cells from human skin is described. The method utilizes enzymatic digestion of skin collagen matrix , followed by plucking of hair follicles and isolation of single cell suspensions or tissue fragments for cell culture.

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin

In this article we demonstrate the isolation of murine resident lung mesenchymal stem cells (lung MSC), their expansion, characterization and analysis of immunomodulatory properties.

Isolation &#38; Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells

A straightforward method is described for the induction of epithelial to mesenchymal transition (EMT) in a variety of cell types.  Methods for the analysis of cells in EMT states by immunocytochemistry are included.

Induction and Analysis of Epithelial to Mesenchymal Transition

Learn differential centrifugation for isolating extracellular vesicles from human mesenchymal stem cells. This reproducible method enables scalable collection of exosomes and microvesicles for therapeutic research.

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Explore More Videos